
Advancements in the Management of Nonmetastatic Castrate-Resistant Prostate Cancer: A Review of Second-Generation ...
Abstract The most common malignancy in men worldwide is prostate cancer, and the prognosis remains favorable with prostate cancer accounting for only 5.7% of all cancer-related deaths. In patients who have localized disease, treatment is dependent on age …